Press Releases

Press Releases

Date Title
1 July 2020 BioNTech to Hold Webcast to Present Early Positive Data from Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
1 July 2020 Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
29 June 2020 BioNTech to Raise USD 250 Million in Private Placement
11 June 2020 Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing
12 May 2020 BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
6 May 2020 BioNTech Completes Acquisition of Neon Therapeutics
5 May 2020 Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
5 May 2020 BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020
29 April 2020 BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
22 April 2020 BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
9 April 2020 Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
31 March 2020 BioNTech Announces Full Year 2019 Financial Results and Corporate Update
23 March 2020 BioNTech to report full year financial results for 2019 and provide corporate update on the fourth quarter on March 31, 2020
17 March 2020 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
16 March 2020 BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
16 March 2020 BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
3 February 2020 BioNTech Announces Commencement of Public Offering of American Depositary Shares
16 January 2020 BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
13 January 2020 BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion
2 January 2020 BioNTech Announces Publication of Preclinical Data for First-in-Kind CAR-T Cell Therapy Approach Targeting Solid Tumors in Science

The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. BioNTech disavows any obligation to update the information contained in such press releases after the date of their issuance.